HUM
Humana Inc.
October 8, 2026 · after-hours
- Rarity
- 3.80
- Peak move
- +17.56%
- Float cap
- $46.6B
Humana Inc. provides medical and specialty insurance products and health care services through its Humana insurance and CenterWell businesses. It serves Medicare and Medicaid participants, families, individuals, and military service personnel, offering HMO, PPO, and prescription drug plans, along with pharmacy, primary care, and home health solutions. As of December 31, 2025, it had approximately 15 million medical benefit plan members and 4.7 million specialty product members.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
5 events · 0 from SEC or newswire · 0 timed with the moveregulatory_approvalCMS published the 2027 Medicare Advantage and Part D Star Ratings on October 8, 2026, with Humana's largest MA contract H5216 recovering to 4 stars from 3.5 and restoring eligibility for federal quality bonus payments affecting 2028 revenue.
litigation_outcomeA federal appeals court heard oral arguments in Humana v. Kennedy, Humana's appeal over HHS rules governing Medicare Advantage RADV audits, and appeared skeptical of HHS's position.
analyst_ratingCantor Fitzgerald analyst Sarah James upgraded Humana to Overweight from Neutral and raised the price target to $460 from $300, citing Medicare Advantage margin and STARS recovery.
class_action_filedU.S. District Judge Jennifer L. Hall ruled that key securities fraud claims against Humana and its former CEO and CFO may proceed, alleging the company misled investors from July 2022 to October 2024 about rising medical costs; Schubert Jonckheer & Kolbe LLP is investigating potential wrongdoing at Humana after that ruling, which followed a 22% stock drop.
product_launchIn October 2026 Humana announced its 2027 Medicare Advantage lineup offering $0 in-network primary care and lab services, dental, vision and hearing benefits, and $0 or low premiums across plans in roughly 2,600 counties.